Geode Capital Management’s Oncolytics Biotech ONCY Stock Holding History
Bought
Maintained
Sold
Other funds holding ONCY
SFP
SI
TAM
EFG
XT
DA
Geode Capital Management's ONCY Position: Q1 2026 in Review
Geode Capital Management held its Oncolytics Biotech (ONCY) position steady in Q1 2026 at 66,939 shares worth $56.8K. The position accounts for ﹤0.01% of the portfolio, ranked #4285.
Geode Capital Management first reported a position in ONCY in Q3 2020 and has held it in 23 quarters since. The position peaked at $93.7K in Q3 2025. 59 funds tracked by Wall St. Rank hold ONCY as of Q1 2026.
- Geode Capital Management held 66,939 shares of Oncolytics Biotech worth $56.8K as of Q1 2026.
- Geode Capital Management left its Oncolytics Biotech share count unchanged in Q1 2026.
- Oncolytics Biotech made up ﹤0.01% of Geode Capital Management's portfolio in Q1 2026, its #4285 holding.
- Geode Capital Management first reported a position in Oncolytics Biotech in Q3 2020 and has held it in 23 quarters since.
- Geode Capital Management's Oncolytics Biotech position peaked at $93.7K in Q3 2025.
- 59 funds tracked by Wall St. Rank held Oncolytics Biotech as of Q1 2026.
Based on Geode Capital Management's 13F filing for Q1 2026, filed 15 May 2026.